-
1
المؤلفون: Simone Birnbaum, Benjamin Rohaut, Judith Mendelson, Francis Bolgert, R. Le Panse, Diane Friedman, Yasmine Domingo, Nicolas Weiss, Bernard Clair, Anthony Behin, Isabelle Ledoux, Frédérique Truffault, Nawal Derridj Ait-Younes, Mélinée Frenkian, Sandra Misdrahi, Guillaume Bassez, Cécilia Orblin Bedos, Jacques Ropers, Tarek Sharshar, B. Eymard, Pierre Portero, S Berrih-Aknin, Sophie Demeret, Philippe Aegerter, Sonia Berrih-Aknin, Estelle Louët, Linda William, Pascal Laforêt, Philippe Thoumie, Raphaël Porcher, Marcela Gargiulo, J.Y. Hogrel, Sylvie Azerad, Elodie Soler, Asmaa Jobic
المساهمون: Institute of Myology Paris France
المصدر: Neuromuscular Disorders
Neuromuscular Disorders, Elsevier, 2021, 31 (8), pp.726-735. ⟨10.1016/j.nmd.2021.05.002⟩مصطلحات موضوعية: Adult, Male, Quality of life, medicine.medical_specialty, Randomization, Exacerbation, [SDV]Life Sciences [q-bio], Rowing, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Autoimmune disease, Clinical endpoint, Humans, Medicine, Prospective Studies, Home based exercise, Myasthenia gravis, Exercise, Genetics (clinical), Aged, Exercise Tolerance, business.industry, Middle Aged, medicine.disease, Exercise Therapy, 3. Good health, Neurology, 030220 oncology & carcinogenesis, Pediatrics, Perinatology and Child Health, Physical therapy, Female, Neurology (clinical), business, 030217 neurology & neurosurgery
-
2
المؤلفون: Mégane Ribot, Céline Verstuyft, Islam Amine Larabi, Nawal Derridj-Ait-Younes, Isabelle Etting, Nicolas Simon, Jean-Claude Alvarez, Sarah Hartley
المساهمون: Hôpital Raymond Poincaré [AP-HP], Plateforme de spectrométrie de masse [Garches] (MasSpecLab), Infection et inflammation (2I), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Hôpital Ambroise Paré [AP-HP], Santé mentale et santé publique (SMSP - U1178), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Sud - Paris 11 (UP11), Hôpitaux Universitaires Paris-Sud Bicêtre (APHP), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Centre antipoison et de toxicovigilance (Marseille) (CAPTV Marseille), Assistance Publique - Hôpitaux de Marseille (APHM), Malbec, Odile
المصدر: British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2021, 87 (8), pp.3139-3149. ⟨10.1111/bcp.14724⟩مصطلحات موضوعية: [SDV]Life Sciences [q-bio], Population, Cmax, Pharmacology, Placebo, oral fluid test, smoked cannabis, Pharmacokinetics, mental disorders, Medicine, Humans, Pharmacology (medical), Dronabinol, education, CYP2C9, Cannabis, education.field_of_study, Cross-Over Studies, biology, Inhalation, business.industry, organic chemicals, Smoking, occasional users, biology.organism_classification, Bioavailability, [SDV] Life Sciences [q-bio], chronic users, Hallucinogens, business, pharmacokinetics
وصف الملف: application/pdf
-
3
المؤلفون: Raphaël Amar, Tristan Thiry, Marjorie Salga, Dominique Safa, Annaëlle Chetrit, Laure Gatin, Robert-Yves Carlier
المساهمون: Hôpital Raymond Poincaré [AP-HP], Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), We thank Julie Poujol (MR Clinical Scientist), Julien Bouvier (Zone Clinical Leader) and Pierre-Frederic Bourcier (MR Clinical Leader Neuro and MSK) from General Electrics Healthcare. We also thank Dr Nawal Derridj-Ait-Younes and her team from the Unit? de Recherche Clinique of H?pital Ambroise Par?., HAL UVSQ, Équipe
المصدر: Journal of Orthopaedic Surgery and Research, Vol 16, Iss 1, Pp 1-11 (2021)
Journal of Orthopaedic Surgery and Research
Journal of Orthopaedic Surgery and Research, BioMed Central, 2021, 16, pp.725. ⟨10.1186/s13018-021-02869-6⟩مصطلحات موضوعية: Adult, Male, [SDV.MHEP.CHI] Life Sciences [q-bio]/Human health and pathology/Surgery, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging, Neurogenic heterotopic ossification, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, Diseases of the musculoskeletal system, Zero Echo Time, Magnetic resonance imaging, Humans, Orthopedics and Sports Medicine, Prospective Studies, Aged, Orthopedic surgery, [SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Hip, Ossification, Heterotopic, Femur Head, Middle Aged, [SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, RC925-935, Female, Surgery, Tomography, X-Ray Computed, RD701-811, Research Article
وصف الملف: application/pdf
-
4
المؤلفون: Diane Friedman, Lamiae Grimaldi, Alain Cariou, Philippe Aegerter, Stéphane Gaudry, Abdel Ben Salah, Haikel Oueslati, Bruno Megarbane, Nicolas Meunier-Beillard, Jean-Pierre Quenot, Carole Schwebel, Laurent Jacob, Ségloène Robin Lagandré, Pierre Kalfon, Romain Sonneville, Shidasp Siami, Aurelien Mazeraud, Tarek Sharshar
المساهمون: Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital Raymond Poincaré [AP-HP], Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Cité - UFR Médecine [Santé] (UPCité UFR Médecine), Université Paris Cité (UPCité), Hôpital Louis Mourier - AP-HP [Colombes], Hôpital Louis Pasteur [Chartres], Hopital Saint-Louis [AP-HP] (AP-HP), Hôpital Lariboisière-Fernand-Widal [APHP], Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Ressources Autisme de Bourgogne (CHU de Dijon) (CRAB), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hôpital Michallon, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CIC Hôpital Bichat, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-UFR de Médecine, Hopital d'instruction des armées Sainte-Anne [Toulon] (HIA), Ministry of Health, MOH: AOM10072, We thank Chanez Lazizi, Sonya Ouali, Sonia Krim, Karima Mesbahi, Chamssedine Mediouni, Layidé Meaudé, and Nawal Derridj-Ait-Younes of the Center for Clinical Epidemiology, we also thank all families and staff at participating sites who agreed to take part in the SUIVI-REA study, and all members of the Trial Steering Committee and Independent Data and Safety Monitoring Committee. This study was funded by the Clinical Research Hospital Program in 2010, and the Ministry of Health confirmed funding under contract number AOM10072. The study funder and co-sponsors play no part in study design, data collection or analysis, writing of the report, or the decision to submit for publication, the responsibility for these activities lies with the Trial Management Group., Results: The study was funded by the Ministry of Health in June 2010. It was approved by the Ethics Committee on July 8, 2011. The first and last patient were randomized on December 20, 2012, and September 1, 2017, respectively. A total of 546 patients were enrolled across 11 ICUs. At present, data management is ongoing, and all parties involved in the trial remain blinded. Conclusions: The SUVI-REA multicenter randomized controlled trial aims to assess whether a post-ICU multidisciplinary follow-up improves QoL at 1 year. Trial Registration: Clinicaltrials.gov NCT01796509, HAL UVSQ, Équipe
المصدر: JMIR Research Protocols
JMIR Research Protocols, 2022, 11 (5), ⟨10.2196/30496⟩مصطلحات موضوعية: cognition, [SDV] Life Sciences [q-bio], quality of life, [SDV]Life Sciences [q-bio], critical illness, General Medicine, Mortality, post intensive care, cognitive impairments, patients, Post-ICU syndrome, post-traumatic, intensive care
وصف الملف: application/pdf
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.